Ensysce Biosciences Inc.
ENSC | NASDAQ
$0.49
-$0.03 (-5.02%)
Sep 11, 2026, 4:00 PM ET · Market open
Market Data
Market Cap $7.93M
Enterprise Value $7M
Beta 0.99
Average Volume 6.02M
Shares Outstanding (Diluted) 13.04M
Shares Change YoY 491.91%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US2936025046
Price Performance
Price Change 1M 16.7%
Price Change 3M 81.5%
Price Change 6M 14.1%
Price Change YTD -47.9%
Price Change 1Y -77.0%
Price Change 3Y -98.1%
Price Change 5Y -100.0%
1M CAGR (ann.) 104.1%
1Y CAGR (ann.) -75.7%
5Y CAGR (ann.) -86.4%
All-Time CAGR -72.9%
Valuation
PE Ratio -0.19
Forward PE N/A
PEG Ratio 0.01
Forward PEG N/A
PS Ratio 6.43
Forward PS 3.00
PB Ratio -9.57
P/FCF Ratio -0.83
P/Adj. FCF Ratio -0.83
P/OCF Ratio -0.72
EV/Sales 6.01
EV/EBIT -0.55
EV/EBITDA -0.56
EV/FCF -0.78
Earnings Yield -514.3%
FCF Yield -120.0%
Adj. FCF Yield -121.0%
Financial Health
Net Cash $479.86K
Total Debt $196.84K
Cash & Short-Term Investments $676.7K
Total Assets $2.96M
Current Ratio 0.70
Quick Ratio 0.70
Debt / Equity Ratio -0.25
Debt / EBITDA -0.02
Debt / FCF -0.02
OCF / Debt -44.99
Interest Coverage -791.64
Altman Z-Score -82.06
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 100.0%
Operating Profit Margin -1087.5%
EBITDA Margin -1083.3%
Net Profit Margin -1084.2%
FCF Margin -771.2%
Adj. FCF Margin -777.2%
SBC / Revenue 6.0%
SBC Impact (per share) -0.8%
Returns
Return on Assets -426.9%
Return on Equity -1532.3%
Return on Invested Capital 1385.3%
Return on Capital Employed 1139.8%
Return on Tangible Assets -426.9%
Historical Growth (CAGR)
Revenue CAGR 3Y N/A
Revenue CAGR 5Y N/A
Revenue CAGR 10Y N/A
EPS CAGR 3Y 32.4%
EPS CAGR 5Y -162.1%
EPS CAGR 10Y N/A
FCF CAGR 3Y 18.6%
FCF CAGR 5Y -107.2%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating N/A
Analyst Count N/A
EPS Growth Next 3Y N/A
Revenue Growth Next 3Y N/A
Earnings Date Nov 12, 2026
EPS Estimate (next Q) -$0.19
EPS Growth Est (next Q) -85.3%
Revenue Est (next Q) $1.2M
Revenue Growth Est (next Q) 143.4%
Cash Flow
Operating Cash Flow $-8.86M
Free Cash Flow $-8.98M
Adj. Free Cash Flow $-9.05M
FCF Per Share -$0.69
OCF Per Share -$0.68
OCF/S Ratio -760.6%
Income Statement
Revenue $1.16M
Gross Profit $1.16M
Operating Income $-12.66M
EBITDA $-12.61M
Net Income $-12.62M
EPS (Diluted) -$2.52
Revenue / Employee $166.33K
Profit / Employee $-1.8M
Employees 7
Add to Watchlist
Select watchlists to add or remove ENSC